Year archive

Jenscare Scientific Co., Ltd. — 2024 filings

All 49 regulatory filings released by Jenscare Scientific Co., Ltd. (9877) in 2024, sourced directly from the official regulator.

49 Filings

2024 Period

2024 filings (49)

Filing	Released	Lang
PROXY FORM FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON WEDNESDAY, JANUARY 15, 2025 Proxy Solicitation & Information Statement	2024-12-30	English
(1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AND (2) NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-12-30	English
NOTICE OF THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Proxy Solicitation & Information Statement	2024-12-30	English
ANNOUNCEMENT BOOK CLOSURE PERIOD FOR THE 2025 FIRST EXTRAORDINARY GENERAL MEETING Declaration of Voting Results & Voting Rights Announcements	2024-12-27	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2024 Regulatory Filings	2024-12-04	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2024 Regulatory Filings	2024-11-05	English
VOLUNTARY ANNOUNCEMENT - RESULTS OF ONE-YEAR CLINICAL FOLLOW-UP OF LUX-VALVE PLUS TRAVEL II STUDY RELEASED AT TCT 2024 IN WASHINGTON, D.C., THE U.S. Regulatory Filings	2024-10-31	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024 Regulatory Filings	2024-10-03	English
2024 Interim Report Interim / Quarterly Report H1 2024	2024-09-25	English
Articles of Association Governance Information	2024-09-20	English
POLL RESULTS OF THE 2024 FIRST EXTRAORDINARY GENERAL MEETING Declaration of Voting Results & Voting Rights Announcements	2024-09-19	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024 Regulatory Filings	2024-09-04	English
CONTINUING CONNECTED TRANSACTION SUPPLEMENTAL ANNOUNCEMENT ON LOAN AGREEMENT FOR REPURCHASE OF INTERESTS IN THE ESOP PLATFORM Capital/Financing Update	2024-09-03	English
PROXY FORM FOR THE 2024 FIRST EXTRAORDINARY GENERAL MEETING TO BE HELD ON THURSDAY, SEPTEMBER 19, 2024 Proxy Solicitation & Information Statement	2024-08-28	English
NOTICE OF 2024 FIRST EXTRAORDINARY GENERAL MEETING AGM Information	2024-08-28	English
(1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION; (2) PROPOSED GRANTING OF GENERAL MANDATE TO REPURCHASE H SHARES; (3) PROPOSED AMENDMENT OF THE H SHARE AWARD SCHEME; (4) PROPOSED Proxy Solicitation & Information Statement	2024-08-28	English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024 Interim / Quarterly Report H1 2024	2024-08-28	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-08-15	English
CONTINUING CONNECTED TRANSACTION - LOAN AGREEMENT FOR REPURCHASE OF INTERESTS IN THE ESOP PLATFORM Capital/Financing Update	2024-08-09	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024 Regulatory Filings	2024-08-06	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024 Regulatory Filings	2024-07-05	English
VOLUNTARY ANNOUNCEMENT RESULTS OF SIX-MONTH CLINICAL FOLLOW-UP OF LUX-VALVE PLUS TRAVEL II STUDY RELEASED Regulatory Filings	2024-07-02	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024 Regulatory Filings	2024-06-04	English
(1) POLL RESULTS OF THE 2023 ANNUAL GENERAL MEETING HELD ON MAY 31, 2024; (2) RE-ELECTION OF DIRECTORS OF THE SECOND SESSION OF THE BOARD; AND (3) RE-ELECTION OF SUPERVISORS OF THE SECOND SE Declaration of Voting Results & Voting Rights Announcements	2024-05-31	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024 Regulatory Filings	2024-05-06	English
PROXY FORM FOR THE 2023 ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 31, 2024 AGM Information	2024-04-26	English
NOTICE OF 2023 ANNUAL GENERAL MEETING AGM Information	2024-04-26	English
1)2023 REPORT OF THE BOARD OF DIRECTORS 2)2023 REPORT OF THE BOARD OF SUPERVISORS 3)2023 AUDITED FINANCIAL STATEMENTS 4)2023 ANNUAL REPORT 5)2023 FINANCIAL ACCOUNTS REPORT 6)2024 FINANCIAL BUDGET 7)20 AGM Information	2024-04-26	English
2023 Annual Report Annual Report FY 2023	2024-04-26	English
INSIDE INFORMATION LUX-VALVE REGISTRATION APPLICATION NOT APPROVED BY THE NMPA Regulatory Filings	2024-04-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024 Share Issue/Capital Change	2024-04-03	English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023 Annual Report FY 2023	2024-03-27	English
Next Day Disclosure Return Share Issue/Capital Change	2024-03-25	English
VOLUNTARY ANNOUNCEMENT JensClip COMPLETED THE ENROLLMENT FOR CONFIRMATORY CLINICAL TRIAL AND ONE-MONTH FOLLOW-UP Regulatory Filings	2024-03-25	English
COMPLETION OF THE H SHARE FULL CIRCULATION Share Issue/Capital Change	2024-03-25	English
ANNOUNCEMENT IN RELATION TO GRANT OF LISTING APPROVAL BY THE STOCK EXCHANGE FOR IMPLEMENTATION OF THE H SHARE FULL CIRCULATION Capital/Financing Update	2024-03-15	English
NOTICE OF BOARD MEETING Regulatory Filings	2024-03-15	English
INSIDE INFORMATION - ISSUANCE OF FILING NOTICE BY THE CSRC IN RESPECT OF THE COMPANY'S H SHARE FULL CIRCULATION APPLICATION Regulatory Filings	2024-03-11	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024 Regulatory Filings	2024-03-06	English
Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-03-04	English
ARRANGEMENT OF ELECTRONIC DISSEMINATION OF CORPORATE COMMUNICATIONS Regulatory Filings	2024-03-04	English
Notification Letter and Reply Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications Regulatory Filings	2024-03-04	English
VOLUNTARY ANNOUNCEMENT LUX-VALVE PLUS SUCCESSFULLY COMPLETED THE FIRST CLINICAL IMPLANTATION IN BRAZIL Regulatory Filings	2024-02-28	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024 Regulatory Filings	2024-02-06	English
VOLUNTARY ANNOUNCEMENT INCREASE IN SHAREHOLDING BY THE CHAIRMAN, EXECUTIVE DIRECTOR AND SENIOR MANAGEMENT Director's Dealing	2024-01-26	English
VOLUNTARY ANNOUNCEMENT SHARE PURCHASE PURSUANT TO THE H SHARE SCHEME Transaction in Own Shares	2024-01-25	English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023 Regulatory Filings	2024-01-05	English
VOLUNTARY ANNOUNCEMENT THE PFO OCCLUDER SYSTEM OMNISEAL SUCCESSFULLY COMPLETED THE FIRST CLINICAL IMPLANTATION Regulatory Filings	2024-01-03	English
VOLUNTARY ANNOUNCEMENT UNUSUAL PRICE AND TRADING VOLUME MOVEMENTS Regulatory Filings	2024-01-02	English